Furthermore, the baseline circulating AQP4 levels were similar between patients and healthy controls but higher in those patients who presented early neurological improvement (defined as a ≥4-point decrease in the NIHSS score compared to the baseline score), either within the first 48 h after stroke onset or at the time of hospital discharge during the recovery phase of the disease [31]. Here, AQP4 is linked to stroke disorder.